These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 17031402)
1. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. Bibi R; Pranesh N; Saunders MP; Wilson MS; O'dwyer ST; Stern PL; Renehan AG Br J Cancer; 2006 Nov; 95(9):1258-64. PubMed ID: 17031402 [TBL] [Abstract][Full Text] [Related]
2. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases. Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201 [TBL] [Abstract][Full Text] [Related]
3. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. McKenney JK; Soslow RA; Longacre TA Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868 [TBL] [Abstract][Full Text] [Related]
4. MUC2 is a molecular marker for pseudomyxoma peritonei. O'Connell JT; Hacker CM; Barsky SH Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214 [TBL] [Abstract][Full Text] [Related]
5. Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients. Jackson SL; Fleming RA; Loggie BW; Geisinger KR Mod Pathol; 2001 Jul; 14(7):664-71. PubMed ID: 11454998 [TBL] [Abstract][Full Text] [Related]
6. Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. Flatmark K; Davidson B; Kristian A; Stavnes HT; Førsund M; Reed W Hum Pathol; 2010 Aug; 41(8):1109-19. PubMed ID: 20338618 [TBL] [Abstract][Full Text] [Related]
8. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus. Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681 [TBL] [Abstract][Full Text] [Related]
9. Pseudomyxoma peritonei--a heterogenous disease. Shen DH; Ng TY; Khoo US; Xue WC; Cheung AN Int J Gynaecol Obstet; 1998 Aug; 62(2):173-82. PubMed ID: 9749889 [TBL] [Abstract][Full Text] [Related]
10. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour. Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980 [TBL] [Abstract][Full Text] [Related]
11. Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry. Guo AT; Song X; Wei LX; Zhao P World J Gastroenterol; 2011 Aug; 17(30):3531-7. PubMed ID: 21941421 [TBL] [Abstract][Full Text] [Related]
12. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. O'Connell JT; Tomlinson JS; Roberts AA; McGonigle KF; Barsky SH Am J Pathol; 2002 Aug; 161(2):551-64. PubMed ID: 12163380 [TBL] [Abstract][Full Text] [Related]
13. Mucinous Balls Tangled With Mesothelial Cells and MUC2-Positive Cancer Cells in the Ascites of Pseudomyxoma Peritonei. Akashi S; Kuwabara H; Yasuda E; Akutagawa H; Takeshita A; Kurisu Y; Egashira Y; Hirose Y; Yuki M; Tsuda Y; Hayashi M Diagn Cytopathol; 2016 Jul; 44(7):628-31. PubMed ID: 27079739 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of single isolated cells with decreased E-cadherin expression in pseudomyxoma peritonei. Koh YW; Jun SY; Kim KR Pathol Int; 2014 Apr; 64(4):164-72. PubMed ID: 24750186 [TBL] [Abstract][Full Text] [Related]
15. Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment. Lohani K; Shetty S; Sharma P; Govindarajan V; Thomas P; Loggie B Ann Surg Oncol; 2014 May; 21(5):1441-7. PubMed ID: 24046117 [TBL] [Abstract][Full Text] [Related]
16. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Ferreira CR; Carvalho JP; Soares FA; Siqueira SA; Carvalho FM Int J Gynecol Cancer; 2008; 18(1):59-65. PubMed ID: 17511804 [TBL] [Abstract][Full Text] [Related]
17. Ovarian mucinous tumor arising in mature cystic teratoma associated with pseudomyxoma peritonei: a case with possible respiratory epithelial differentiation. Stewart CJ; Junckerstorff R; Tsukamoto T Int J Gynecol Pathol; 2008 Jan; 27(1):41-3. PubMed ID: 18156973 [No Abstract] [Full Text] [Related]
18. [Clinicopathologic characteristics and histogenesis of mucinous tumor of peritoneum]. Zhang H; Sun Y; Huang X; Jia L; Bai Y; Cao D Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):163-8. PubMed ID: 24842014 [TBL] [Abstract][Full Text] [Related]
19. Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei. Choudry HA; Mavanur A; O'Malley ME; Zeh HJ; Guo Z; Bartlett DL Ann Surg Oncol; 2012 May; 19(5):1402-9. PubMed ID: 22302271 [TBL] [Abstract][Full Text] [Related]
20. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis. Shetty S; Thomas P; Ramanan B; Sharma P; Govindarajan V; Loggie B J Surg Res; 2013 Mar; 180(1):97-103. PubMed ID: 23199549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]